Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-841P is classified as a pseudogene related to the U6 snRNA, an essential RNA component of the spliceosome in eukaryotic cells. U6 snRNA itself is critical for pre-mRNA splicing, but many organisms, including humans, have multiple non-functional pseudogenes like RNU6-841P that do not produce functional RNA products[4][7][3]. Pseudogenes typically result from gene duplication or retrotransposition events and in most cases are transcriptionally silent or non-functional. While some pseudogenes in the genome have been shown to act as regulators of gene expression (through mechanisms such as competing endogenous RNA activity), there is no evidence that RNU6-841P has any such function or relevance in disease, drug interaction, or as a therapeutic target[4][7][6]. This entry is correctly named and classified, but is not a functional gene, receptor, or therapeutic target[4][7].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 841, pseudogene (RNU6-841P).